CCA
CRL icon

Criterion Capital Advisors’s Charles River Laboratories CRL Stock Holding History

Criterion Capital Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$6.82K Hold
33
– – ﹤0.01% 278
2024
Q3 		$6.82K Hold
33
– – ﹤0.01% 278
2024
Q2 		$6.82K Hold
33
– – ﹤0.01% 278
2024
Q1 		$8.94K Hold
33
– – 0.01% 267
2023
Q4 		$7.8K Buy
+33
New +$6.49K 0.01% 277

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return

Criterion Capital Advisors's CRL Position: Q4 2024 in Review

Criterion Capital Advisors held its Charles River Laboratories (CRL) position steady in Q4 2024 at 33 shares worth $6.82K. The position accounts for ﹤0.01% of the portfolio, ranked #278.

Criterion Capital Advisors first reported a position in CRL in Q4 2023 and has held it in 5 quarters since. The position peaked at $8.94K in Q1 2024. 635 funds tracked by Wall St. Rank hold CRL as of Q4 2024.

  • Criterion Capital Advisors held 33 shares of Charles River Laboratories worth $6.82K as of Q4 2024.
  • Criterion Capital Advisors left its Charles River Laboratories share count unchanged in Q4 2024.
  • Charles River Laboratories made up ﹤0.01% of Criterion Capital Advisors's portfolio in Q4 2024, its #278 holding.
  • Criterion Capital Advisors first reported a position in Charles River Laboratories in Q4 2023 and has held it in 5 quarters since.
  • Criterion Capital Advisors's Charles River Laboratories position peaked at $8.94K in Q1 2024.
  • 635 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2024.

Based on Criterion Capital Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.